login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NASUS PHARMA LTD (NSRX) Stock News
USA
-
NYSE Arca
- NYSEARCA:NSRX -
IL0012181553
-
Common Stock
7
USD
-0.25 (-3.45%)
Last: 11/25/2025, 8:04:00 PM
7.31
USD
+0.31 (+4.43%)
After Hours:
11/11/2025, 5:35:42 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NSRX Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Nasus Pharma, Ltd.
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
9 days ago - By: Nasus Pharma, Ltd.
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
2 months ago - By: Benzinga
- Mentions:
PRPH
ABP
WORX
COSM
...
12 Health Care Stocks Moving In Friday's After-Market Session
2 months ago - By: Benzinga
- Mentions:
PDEX
IRWD
ENTA
SCYX
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
3 months ago - By: Nasus Pharma, Ltd.
Nasus Pharma Announces Upcoming Presentation at H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Nasus Pharma, Ltd.
Nasus Pharma Announces Closing of Initial Public Offering
4 months ago - By: Nasus Pharma, Ltd.
Nasus Pharma Announces Pricing of $10 Million Initial Public Offering
Please enable JavaScript to continue using this application.